Sujata Wangkheimayum

No ORCID on file · 2 papers in corpus

article 2025

Danazol causes significant changes in the cardiometabolic profile of patients with acquired aplastic anaemia

·doi:10.1016/j.bcmd.2025.102921

BackgroundDanazol is frequently used in treating patients with acquired aplastic anaemia (AA) in resource-constraint settings. We aimed to evaluate the cardiometabolic side effects of Danazol in patients with AA.MethodsThis prospective stud…

article 2015

Effect of danazol on cardiac, hematological, biochemical parameters and lipid profile in aplastic anemia patients

·doi:10.1016/j.ihj.2015.10.219